Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Intellia Therapeutics Inc (NASDAQ: NTLA) closed at $22.15 down -1.42% from its previous closing price of $22.47. In other words, the price has decreased by -$1.42 from its previous closing price. On the day, 1.43 million shares were traded. NTLA stock price reached its highest trading level at $22.44 during the session, while it also had its lowest trading level at $21.6.
Ratios:
For a deeper understanding of Intellia Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.03 and its Current Ratio is at 9.03. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on February 23, 2024, Downgraded its rating to Neutral and sets its target price to $32 from $136 previously.
On April 13, 2023, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $66.Canaccord Genuity initiated its Buy rating on April 13, 2023, with a $66 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 17 ’24 when Verwiel Frank sold 1,505 shares for $25.00 per share. The transaction valued at 37,625 led to the insider holds 17,948 shares of the business.
BASTA JAMES sold 2,297 shares of NTLA for $75,778 on Mar 04 ’24. The EVP, General Counsel now owns 81,571 shares after completing the transaction at $32.99 per share. On Mar 04 ’24, another insider, Clark Eliana, who serves as the EVP, Chief Technical Officer of the company, sold 605 shares for $32.99 each. As a result, the insider received 19,959 and left with 71,470 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NTLA now has a Market Capitalization of 2167802624 and an Enterprise Value of 1456499584. For the stock, the TTM Price-to-Sale (P/S) ratio is 40.63 while its Price-to-Book (P/B) ratio in mrq is 2.06. Its current Enterprise Value per Revenue stands at 27.688 whereas that against EBITDA is -2.868.
Stock Price History:
The Beta on a monthly basis for NTLA is 1.81, which has changed by -0.4524104 over the last 52 weeks, in comparison to a change of 0.23886502 over the same period for the S&P500. Over the past 52 weeks, NTLA has reached a high of $46.50, while it has fallen to a 52-week low of $19.37. The 50-Day Moving Average of the stock is -6.33%, while the 200-Day Moving Average is calculated to be -18.40%.
Shares Statistics:
For the past three months, NTLA has traded an average of 1.58M shares per day and 2229470 over the past ten days. A total of 96.48M shares are outstanding, with a floating share count of 94.57M. Insiders hold about 1.97% of the company’s shares, while institutions hold 91.29% stake in the company. Shares short for NTLA as of 1718323200 were 13741636 with a Short Ratio of 8.69, compared to 1715731200 on 15167458. Therefore, it implies a Short% of Shares Outstanding of 13741636 and a Short% of Float of 16.350001.
